Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of -2.31 is in distress zone. This implies bankruptcy possibility in the next two years.
Global Bio-chem Technology Group Co has a Altman Z-Score of -2.31, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
Global Bio-chem Technology Group Co (HKSE:00809) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Bio-chem Technology Group Co Altman Z-Score Chart
For the Packaged Foods subindustry, Global Bio-chem Technology Group Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Bio-chem Technology Group Co Altman Z-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Global Bio-chem Technology Group Co's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Global Bio-chem Technology Group Co's Altman Z-Score falls into.
Global Bio-chem Technology Group Co Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Global Bio-chem Technology Group Co (HKSE:00809) has a Altman Z-Score of -2.31 as of Aug. 10, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Global Bio-chem Technology Group Co and its competitors. According to the industry distribution chart, Global Bio-chem Technology Group Co ranks #1852 out of 1932 companies in the Consumer Packaged Goods industry, placing it in the top 95.9%.
Is Global Bio-chem Technology Group Co's Altman Z-Score too high?
Global Bio-chem Technology Group Co's current Altman Z-Score is -2.31. Based on the distribution chart, Global Bio-chem Technology Group Co ranks #1852 out of 1932 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Global Bio-chem Technology Group Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Global Bio-chem Technology Group Co's Altman Z-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Global Bio-chem Technology Group Co ranks #1852 out of 1932 companies for Altman Z-Score. This places Global Bio-chem Technology Group Co in the lower half of its industry. The industry median Altman Z-Score is 2.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Consumer Packaged Goods company?
The median Altman Z-Score among Consumer Packaged Goods companies is 2.89, based on 1,932 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Global Bio-chem Technology Group Co and its competitors. For the Consumer Packaged Goods industry, the median Altman Z-Score is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Bio-chem Technology Group Co's current Altman Z-Score is -2.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Bio-chem Technology Group Co stock overvalued right now?
Global Bio-chem Technology Group Co (HKSE:00809) has a current Altman Z-Score of -2.31. The current Altman Z-Score is -2.31. Global Bio-chem Technology Group Co's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Global Bio-chem Technology Group Co (HKSE:00809), the current Altman Z-Score is -2.31 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Global Bio-chem Technology Group Co Ltd is engaged in the manufacture and sale of corn refined products and amino acids. The upstream corn refinery serves as a feedstock which breaks down corn kernels into corn starch, gluten meal, fibre and corn oil; and corn starch is further refined through a series of biochemical and/or chemical processes into a wide range of high value-added downstream products. Its segments include the upstream products segment; and the amino acids segment engages in the manufacture and sale of corn based biochemical products, including lysine and threonine. It derives the majority of the revenue from the amino acids segment. Geographically, it operates in The PRC, and Asia, the Americas and other regions.
33GF Score
Get the complete analysis for HKSE:00809
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00809 has been successfully added to your 
